United States · FDA National Drug Code directory
ATZUMI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76978-101_08783e1b-71b6-4187-8adc-ab72bf9c2c8c
- Product NDC
- 76978-101
- Form
- POWDER
- Composition / generic term
- DIHYDROERGOTAMINE MESYLATE
- Labeler
- Satsuma Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250430
- Source listing expiry
- 20271231
Source-listed ingredients
- DIHYDROERGOTAMINE MESYLATE — 5.2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 8 BOTTLE, UNIT-DOSE in 1 CARTON (76978-101-08) / 1 POWDER in 1 BOTTLE, UNIT-DOSE · 76978-101-08
- 1 BOTTLE, UNIT-DOSE in 1 CARTON (76978-101-11) / 1 POWDER in 1 BOTTLE, UNIT-DOSE · 76978-101-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →